{"id":"W2035105453","doi":"10.1007/s10637-009-9230-z","title":"A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503","year":2009,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saint-Vincent Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Gemcitabine; Medicine; Internal medicine; Regimen; Lung cancer; Overall survival; Oncology; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001976415,0.002075808,0.003927079,0.0008069659,0.0006408808,0.001280266,0.001551579,0.002200023,0.00685222],"category_scores_gemma":[0.001080027,0.0009088992,0.002649654,0.0008507752,0.001355812,0.001255986,0.0005387251,0.005398918,0.001762623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001458371,"about_ca_system_score_gemma":0.003128923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003770024,"about_ca_topic_score_gemma":0.0110237,"domain_scores_codex":[0.9994038,0.0002831126,0.00002724939,0.00009997954,0.00003526188,0.0001505461],"domain_scores_gemma":[0.9987105,0.0001997201,0.0001415782,0.00009971248,0.00004891206,0.0007995144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8835042,0.05012492,0.00354538,0.0004245544,0.001535588,0.0002689289,0.0002112224,0.001769803,0.0153667,0.0002545012,0.004587403,0.03840683],"study_design_scores_gemma":[0.7254609,0.2651646,0.005290014,0.00001972352,0.000460225,0.0002010529,0.00006009339,0.0007850743,0.00105637,0.0001481868,0.001321675,0.00003205414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904268,0.001496303,0.0004486882,0.0006939048,0.0002891293,0.002379885,0.002002206,0.0001224776,0.002140616],"genre_scores_gemma":[0.9802106,0.002432992,0.001813058,0.001587355,0.000300362,0.003443876,0.005132403,0.0000774561,0.00500202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00685222,"threshold_uncertainty_score":0.02292293,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02281362557493624,"score_gpt":0.3220910436634508,"score_spread":0.2992774180885146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}